Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT03673527
PHASE1
Tacrolimus Blood Levels After Topical Application of Tacrolimus on Healthy Skin
Sponsor: LEO Pharma
View on ClinicalTrials.gov
Summary
This is a phase I trial to evaluate tacrolimus blood levels after topical application of tacrolimus twice daily on healthy skin.
Official title: Open-label, Non-randomised, Single-centre, Multiple-dose, Phase 1, Pharmacokinetic Trial With a Topical Formulation of Tacrolimus in Healthy Subjects
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2018-11-22
Completion Date
2019-02-11
Last Updated
2026-04-28
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
topical formulation of tacrolimus
Topical application of tacrolimus twice daily for 14 days (one dose on Day 14).
Locations (1)
Investigational site
Neu-Ulm, Bavaria, Germany